enGene Therapeutics Inc.
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell ENGN and other ETFs, options, and stocks.About ENGN
enGene Therapeutics, Inc. is a clinical-stage biotechnology company, which engages in developing gene therapies. It is developing non-viral gene therapies based on its novel and proprietary dually derived chitosan, or DDX, gene delivery platform, which allows localized delivery of multiple gene cargos directly to mucosal tissues and other organs.
ENGN Key Statistics
Stock Snapshot
enGene Therapeutics Inc.(ENGN) stock is priced at $1.76, giving the company a market capitalization of 117.57M. It carries a P/E multiple of -0.74.
During the trading session on 2026-06-04, enGene Therapeutics Inc.(ENGN) shares reached a daily high of $1.77 and a low of $1.68. At a current price of $1.76, the stock is +4.4% higher than the low and still -0.8% under the high.
Trading volume for enGene Therapeutics Inc.(ENGN) stock has reached 424.32K, versus its average volume of 1.28M.
Over the past 52 weeks, enGene Therapeutics Inc.(ENGN) stock has traded between a high of $12.25 and a low of $1.40.
Over the past 52 weeks, enGene Therapeutics Inc.(ENGN) stock has traded between a high of $12.25 and a low of $1.40.
Analyst ratings
62%
of 13 ratingsPeople also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.